English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90453/105671 (86%)
Visitors : 15638540      Online Users : 81
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/113081

    Title: Andrographolide mitigates cardiac apoptosis to providecardio-protection in high-fat-diet-induced obese mice
    Authors: Lin, Kuan-Ho;Lin, Kuan-Ho;Martha, Shibu;Asokan, Shibu Marthandam;Kuo, Wei-Wen;Kuo, Wei-Wen;謝宥諒;Hsieh, You-Liang;Chong-Kuei, L;Lii, Chong-Kuei;Vijayapadma;Viswanadha, Vijayapadma;Lin, Yi-Lin;Lin, Yi-Lin;Wang, Shulin;Wang, Shulin;Yang, Caixian;Yang, Caixian;黃志揚;Huang, Chih-Yang
    Contributors: 醫學檢驗暨生物技術學系
    Keywords: Andrographis paniculata;cardiac apoptosis;cell survival;high fat diet;obesity.
    Date: 2020-01
    Issue Date: 2020-10-15 14:28:07 (UTC+8)
    Publisher: 亞洲大學
    Abstract: Excessive intake of high fat diet (HFD) and associated obese conditions are critical contributors of cardiac diseases. In this study, an active metabolite andrographolide from Andrographis paniculata was found to ameliorate HFD-induced cardiac apoptosis. C57/BL6 mouse were grouped as control (n = 9), obese (n = 8), low dose (25 mg/kg/d) andrographolide treatment (n = 9), and high dose (50 mg/kg/d) andrographolide treatment (n = 9). The control group was provided with standard laboratory chow and the other groups were fed with HFD. Andrographolide was administered through oral gavage for 1 week. Histopathological analysis showed increase in apoptotic nuclei and considerable cardiac-damages in the obese group signifying cardiac remodeling effects. Further, Western blot results showed increase in pro-apoptotic proteins and decrease in the proteins of IGF-1R-survival signaling. However, feeding of andrographolide significantly reduced the cardiac effects of HFD. The results strongly suggest that andrographolide supplementation can be used for prevention and treatment of cardiovascular disease in obese patients.
    Appears in Collections:[醫學檢驗暨生物技術學系] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in ASIAIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback